Pasquali et al., 2008 - Google Patents
Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in micePasquali et al., 2008
View PDF- Document ID
- 809283695583017171
- Author
- Pasquali P
- Ammendola S
- Pistoia C
- Petrucci P
- Tarantino M
- Valente C
- Marenzoni M
- Rotilio G
- Battistoni A
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
Salmonella enterica has long been recognised as an important zoonotic pathogen of economic significance, both in animals and humans. We have recently shown that inactivation of the ZnuABC high affinity zinc transporter significantly affects the pathogenicity …
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium 0 title abstract description 92
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cornelis et al. | Yersinia enterocolitica, a primary model for bacterial invasiveness | |
| US10046040B2 (en) | Multivalent live vector vaccine against Clostridium difficile-associated disease | |
| DiPetrillo et al. | Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers | |
| Frey | Biological safety concepts of genetically modified live bacterial vaccines | |
| ES2286905T3 (en) | PLASMID STABILIZATION SYSTEM FOR THE SUPPLY OF ANTIGENS. | |
| Curtiss III et al. | Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry | |
| Ciabattini et al. | Oral priming of mice by recombinant spores of Bacillus subtilis | |
| Pasquali et al. | Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice | |
| Homchampa et al. | Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant | |
| CN101801408A (en) | Electroporation of mycobacteria and overexpression of antigens in mycobacteria | |
| CA2323576C (en) | Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines | |
| Wang et al. | Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines | |
| Jawale et al. | Characterization of adaptive immune responses induced by a new genetically inactivated Salmonella Enteritidis vaccine | |
| Cai et al. | Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice | |
| Zhang et al. | The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice | |
| Cunningham et al. | Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates | |
| CA2760098C (en) | Mutants of francisella tularensis and uses thereof | |
| Pathangey et al. | Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines | |
| Yang et al. | Evaluation of recombinant Salmonella vaccines to provide cross-serovar and cross-serogroup protection | |
| Uzzau et al. | Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep | |
| Truong et al. | Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus | |
| Liu et al. | Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a | |
| Oyston et al. | A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection | |
| Pan et al. | Flagellin from recombinant attenuated Salmonella enterica serovar Typhimurium reveals a fundamental role in chicken innate immunity | |
| Yevsa et al. | Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology |